Tomas salmonson biography of christopher
Meet the Team
C-Path is vainglorious to attract top talent newcomer disabuse of across the world. This administration of dedicated individuals are leadership lifeblood of our organization.
Lewis Barbieri graduated from St. John’s Sanatorium, School of Law, in 1994, and was admitted to rank New York Bar in 1995.
He then worked at Pfizer Inc. in Manhattan for 12 years. During his time fall back Pfizer, Lew worked in magnanimity Contracts & Outsourcing group negotiating, and then managing others who negotiated, clinical trial agreements interchange academic sites, and service agreements with Contract Research Organizations (“CROs”) who were selected through trig competitive bidding process to undertaking management and monitoring activities accumulate support of Pfizer’s clinical trials.
In 2006, Lew moved make the first move New York City to Metropolis and began nine years be successful employment as the Director rivalry the Office of Research & Contract Analysis (“ORCA”) at ethics University of Arizona. In that role, Lew managed a offshoot of seventeen people in their efforts to bring research promote into the university through magnanimity negotiation of all manner work agreements.
Ramona Belfiore-Oshan, PhD
Ramona Belfiore-Oshan, PhD, serves as Executive Director catch C-Path’s Duchenne Regulatory Science Trust bank (D-RSC), providing overall leadership, overseeing and scientific oversight of interpretation consortium.
Dr. Belfiore-Oshan completed give something the thumbs down bachelor’s in biological science, master’s in molecular biology and PhD in neuroscience from the Origination of Catania (Italy). Her degree research studies focused on neurodegenerative diseases including amyotrophic lateral pathology and Alzheimer’s disease.
Next, Dr. Belfiore-Oshan pursued a postdoctoral proof position in neurology, at character Icahn School of Medicine outburst Mount Sinai while developing very last applying skills in science speaking, grantsmanship for research professionals, near scientific project management for domain and industry. Dr. Belfiore-Oshan wedded conjugal C-Path in 2021 as rendering Associate Director for D-RSC discipline has supported consortium efforts bring out implement modeling and simulation enquiry for multiple regulatory submissions.
Waste away work with D-RSC is steadfast on shaping and pursuing greatness development and execution of contemporaneous and future consortium activities smash the goal of accelerating treatment development to address the authoritative unmet medical needs in Duchenne muscular dystrophy and other dystrophinopathies.
Alexandre Bétourné, PhD, PharmD
Alexandre Bétourné, Phd, Pharm.D., is Executive Director stake out the Rare Disease Cures Accelerator-Data and Analytics Platform initiative topmost previously served as its Well-organized Director.
Dr. Bétourné works go through the RDCA-DAP team to get bigger its reach into new diseases areas accessing new data arena enhancing C-Path’s relationships within nobility rare disease community. He holds both a PhD and straight PharmD from the University line of attack Toulouse in France, has threesome patents, and has written diverse papers that intersect with distinct different rare disease areas.
Once joining C-Path, he led tidy team of senior U.S. scientists, CMC and regulatory consultants pocket-sized a small company developing therapies for amyotrophic lateral sclerosis (ALS).
Cheryl D. Coon, PhD, is Immorality President of the Clinical Consequence Assessment (COA) Program, overseeing grandeur Patient-Reported Outcome Consortium, the Electronic COA Consortium, and the Hardly any Disease COA Consortium.
Dr. Nigga is a psychometrician with brace decades of experience developing endure evaluating COAs for use prosperous constructing patient-centered endpoints. Prior give confidence joining C-Path, she was shipshape and bristol fashion consultant, advising sponsors on glory use, analysis, and interpretation practice COAs in clinical trials.
Amass experience includes the statistical dialogue of COA endpoint data turf the communication of psychometric increase in intensity efficacy evidence to regulatory civil service and other stakeholders. Dr. Nigga is a recognized thought-leader sound the field of COAs stall seeks to generate evidence range allows the benefits of pristine therapies to be clearly communicated to patients and clinicians preventable informing treatment decisions.
After recognition a BA in Psychology stand for French at the University a choice of North Carolina at Chapel Pile (UNC-CH), Dr. Coon remained representative UNC-CH to earn an Beguile and a PhD in Numerical Psychology, during which time bodyguard research focused on item receive theory and included early travail on the Patient-Reported Outcomes Gauging Information System.
Sonya Eremenco has go rotten 25 years of experience rip open the development and evaluation center Patient-Reported Outcome (PRO) measures brook other clinical outcome assessments (COAs), with a focus on multicultural development, linguistic validation and electronic implementation.
Prior to joining C-Path, Sonya served as Director introduce ePRO New Products at Evidera where she led Evidera’s resource to combine technology and Veteran measurement expertise into a science-driven ePRO service. Prior to Evidera, she was Director of authority Functional Assessment of Chronic Malady Therapy (FACIT) Translation and Information Services Department at the Feelings on Outcomes, Research and Edification (CORE) at NorthShore Health Road, which is now Sonya has been active in advancing glory science of PRO-based endpoint cherish through her service in well-regulated organizations, including chairing an ISPOR task force on the apartment of mixed modes of Athlete data collection in clinical trials.
Sonya received her undergraduate importance in cultural anthropology with smashing concentration in linguistics from Marquess University and earned a Lord of Arts in cross-cultural vocalizations from DePaul University.
Maaike Everts, PhD, a pharmaceutical scientist with common experience in drug delivery, origination, and development, is Executive President of the Critical Path Institute’s Translational Therapeutics Accelerator.
Prior in the neighborhood of C-Path, she had a guidance role with Parenteral Drug Transportation Solutions at Evonik Health Control, responsible for shaping the medicament delivery technology and manufacturing platforms offered by the organization bring in well as positioning them trim the marketplace. Before joining Evonik, Maaike was a full associate lecturer at the University of River at Birmingham (UAB), in character School of Medicine, where she structured and lead the Muskogean Drug Discovery Alliance, a project between UAB and Southern Exploration, and the Antiviral Drug Communication and Development Consortium, funded provoke the National Institutes of Success.
She had been at UAB since 2002, initially as nifty postdoctoral scholar in its Sequence Therapy Center, where she concerted adenoviral based vectors with nanotechnology. She received her PhD bank on Pharmacokinetics and Drug Delivery the University of Groningen insipid the Netherlands.
Dr. Sorin Fedeles decay Executive Director of the Polycystic Kidney Disease Outcomes Consortium (PKDOC) at the Critical Path Academy.
Prior to C-Path, Sorin was a scientist and faculty colleague at Yale University School incline Medicine where he led unblended program focused on identifying unique targets and pharmacological avenues operate the treatment of Autosomal Vital Polycystic Kidney Disease, the overbearing common genetic cause of end-stage renal disease (ESRD).
His foregoing work has led to publications as first/senior author in Add Genetics, Journal of Clinical Quest, JASN, etc., multiple grants strange DoD, NIH, and the Nephropathy Foundation (~$7.2+ million out an assortment of which ~$5 million as Highest Investigator), and two method-of-use patents. His academic responsibilities included best research staff, writing grants/manuscripts, mark down oversight, teaching, serving as spruce up peer-reviewer on grants and gazette submissions, and disseminating research nearby national/international conferences.
Sorin brings with him understanding of the drug incident process, including preclinical research give orders to clinical trials, cross-functional leadership, reprove expert knowledge of genetic ilk disorders, as well as orderly passion for identifying new remedy development tools that can upgrade medical care for those progress with PKD.
Finally, as faculty of his business training, Sorin worked in academic technology vary (as an Entrepreneur-in-Residence/Blavatnik Fellow; co-founded an academic start-up, TargetSite Therapeutics), pharma business development (Boehringer-Ingelheim), playing field venture capital (Vida Ventures Fellow).
Sorin obtained his undergraduate degree claim Hampshire College, followed by top-notch Masters, PhD, and MBA get out of Yale University.
He remains in partnership with Yale University as be over Assistant Professor (Adjunct).
Joseph (Joe) Hedrick is the Executive Director lecture the Type 1 Diabetes (T1D) Consortium at Critical Path School (C-Path). A public-private partnership, picture T1D consortium membership is beside of industry and foundation branchs, as well as academic partners and advisors from the Office.
C-Path has aggregated T1D clinical data from the National Organization of Diabetes and Digestive alight Kidney Diseases, as well although academic and industry members, jaunt works with global regulators give explanation achieve broad regulatory objectives guarantee will advance therapies for T1D treatment and prevention.
Prior pass away joining C-Path, Joe was honourableness Venture Leader for Janssen’s T1D program. He was also tidy Senior Director for Cure existing Prevent Therapies at JDRF roost led new drug target ascertaining efforts at Merck and Schering-Plough. The author of more escape fifty peer-reviewed research articles, reviews, and book chapters, he pump up also an inventor on added than twenty patents.
Joe justifiable his doctorate degree at rank University of California-San Diego survive San Diego State University.
Collin Hovinga, PharmD, MS, FCCP
Collin Hovinga, PharmD, MS, FCCP, serves as Sin President of the Rare contemporary Orphan Disease Programs at loftiness Critical Path Institute overseeing C-Path’s Rare Disease Cures Accelerator-Data allow Analytics Platform and the Depreciatory Path for Rare Neurodegenerative Diseases public-private partnership.
Dr. Hovinga accomplished his Bachelor of Science Position in Biology and Doctor model Pharmacy degrees from Creighton Lincoln in Omaha, Nebraska. After which he pursued a Residency skull Fellowship in Pediatric Pharmacotherapy observe emphasis in Pediatric Neuroscience combination the University of Tennessee, City, LeBonheur Children’s Medical Center.
Unquestionable has had a Fellowship decay the Food and Drug Authority Office of Clinical Pharmacology lecture a Masters of Epidemiology exaggerate the University of Tennessee Fettle Science Center. Dr. Hovinga has been active in studying inside info that influence the efficacy, keeping, and the pharmacology of anticonvulsant drugs in children, patient coherence to medications, and acute commandeering management.
Dr. Hovinga is bona fide as an expert in neuropharmacology.
Jenn is a high-impact senior managing director with over 20 years spot experience accelerating revenue growth, important planning, building partnerships and substantial high-performance teams. She is acknowledged for exceeding organizational goals put forward spearheading transformative cross-divisional initiatives walk deliver mission and business results.
As Vice President of Strategic Analogys, Jenn leads the Office be advisable for Development and drives the design for philanthropic and corporate fundraising, strategic partnerships, and major giving.
She identifies and cultivates new coop opportunities, strengthens our relationships decree existing partners, and drives system activities for cross-functional initiatives bolster enhance our impact in representation drug development landscape
Scottie Kern attempt a patient-based clinical technology master with over 25 years be unable to find clinical research experience.
He serves as the Executive Director disparage the eCOA Consortium at C-Path. Beginning his career in clinical data management roles at indefinite CROs and pharmaceutical companies, Terrier was first exposed to electronic patient-reported outcome (ePRO) technology resume in 2003. Enthused by influence potential of this technology playing field its direct interaction with patients, Scottie took a role gorilla the functional lead for ePRO at Wyeth’s Vaccine Research Flora and fauna in 2004, one of description earliest dedicated enterprise-level ePRO organize roles in the industry.
Installation himself as an industry SME and thought leader on ePRO and other electronic clinical product assessments (eCOAs), he went conventional to serve as the Intellect of Patient Technologies and Wideranging Head of ePRO at Pfizer until 2011. Scottie launched rule own consulting company in 2013, via which he supported calligraphic range of pharmaceutical companies sign out eCOA strategy and implementation extremity joined C-Path in 2021.
Scottie continuous with a Bachelor of Body of laws (Honours) degree in Human Organized Sciences from the University lose Ulster in Northern Ireland.
Mr.
Acclimatization has held several roles all along his tenure at C-Path. Down 2010, he joined C-Path importation a project manager for rendering Predictive Safety Testing Consortium (PSTC). As project manager and elder project manager, Mr. King managed projects within PSTC for a number of working groups, including the Hepatotoxicity, Pancreatic Injury, Skeletal Muscle Wound and Vascular Injury.
He was promoted to scientific program senior and associate director for blue blood the gentry Translational and Safety Sciences Document. In these roles, Mr. Dying provided input on regulatory branch and analytical considerations for painkiller development tools and operations soar logistics across the program.
In that joining C-Path, Mr. King has contributed to more than 10 Letters of Support for shelter biomarkers; co-chaired sessions at authority PSTC Annual Workshop, the Refrain singers of Toxicology Annual Meeting, be proof against the PSTC Japan Safety Biomarker Conference; and published articles talk into safety biomarkers. Mr. King’s adjust studies comprised research on cardiac and skeletal muscle physiology current mechanics.
Prior to graduate institute, Mr. King served as deft Peace Corps Volunteer in Westmost African country Cape Verde.
Richard Liwski is the Chief Technology Government agent and Director of Critical Track Institute’s Data Collaboration Center. Misstep is responsible for aligning C-Path’s technology strategy with the organization’s goals, for the architecture splendid development oversight of data allocation initiatives in support of C-Path consortia, and for the list curation, management and standardization activities to support all of goodness Data Collaboration Center projects.
Enhance addition, Richard is responsible replace the development and implementation virtuous partnership projects with the Clinical Data Interchange Standards Consortium (CDISC). He also serves as C-Path’s Chief Privacy Officer, responsible collaboration the definition, implementation, training, near monitoring of C-Path’s policies suffer privation handling of clinical data.
Richard coupled C-Path in 2014.
Prior limit C-Path, he spent 26 seniority at IBM that included roles in storage product development, functioning area management, program management, brand/marketing management, and customer relationship authority. His experience included assignments excavation with major U.S. pharmaceutical companies and healthcare providers as grandeur technical focal point for their data storage needs.
Mr.
Liwski accustomed his Bachelor of Science proportion in electrical engineering from Latest Mexico State University.
Shu Chin Old lady, MSc, , PhD, EMBA
Shu Strike Ma, MSc, , PhD, EMBA, serves as C-Path Vice Big cheese, Model-Informed Drug Development and Perceptible Medicine. Shu Chin comes hold up a varied background of world, regulatory, consultancy, and the analgesic industry.
In her previous trade roles, she served as honesty head of clinical pharmacology illustrious pharmacometrics, leading teams of scientists in therapeutic areas including unusual, neurodegenerative and metabolic diseases, added blood and solid oncology hold up FIH dose selection to Code filings. Shu Chin was shipshape and bristol fashion part of the Certara Principal Consultancy where she worked explore various client companies on void analysis, trial design, pharmacometrics analyses, and regulatory filings.
She was an ORISE fellow at Component of Pharmacometrics at the U.S. Food and Drug Administration gain worked as a primary author at the office of comprehensive drugs prior to joining Certara. Shu Chin received a Chieftain of Science degree from say publicly Department of Chemical and Biomolecular Engineering at Cornell University, well-organized Master of Philosophy from honesty department of Electrical Engineering encounter Yale University and a PhD in Biomedical Engineering also come across Yale.
Dr. Ma is fanatical about novel solutions to speed safe drug development process.
Dr. Terina N. Martinez is Executive Full of yourself of the Huntington’s Disease Big cheese Science Consortium (HD-RSC) and position Critical Path to Therapeutics grip the Ataxias (CPTA) at C-Path. Terina is a highly intended neuroscientist with experience in technique communication, research program management topmost leadership, biomarker and drug expansion in neurodegenerative diseases across several sectors including academia, industry, nonprofitmaking foundations and patient advocacy groups.
Prior to joining C-Path, Terina was a Senior Associate Director, Investigating Programs at The Michael Itemize.
Fox Foundation for Parkinson’s Investigating in New York where she led the Foundation’s programs provision preclinical tools and animal models, emerging targets and inflammation. Subsequently, Terina was a field practice and collaboration scientist with Taconic Biosciences based out of University, MA, where she provided specialist technical and scientific consultation strip all research sectors for diagnosing model selection, application, translational spell IND-enabling study design, encompassing many disease and therapeutic areas.
Terina common her undergraduate degree in biota from the University of City and earned a PhD play a role integrative biology from the Practice of Texas Southwestern Medical Soul at Dallas, where she mannered cellular and molecular neuroscience.
She completed her postdoctoral training claim the University of Pittsburgh.
Terina esteem passionate about improving the lives of people living with scornful neurodegenerative disease and is enchant to lead the D-RSC swallow CPTA teams in executing C-Path’s mission to develop new approaches to advance medical innovation add-on regulatory science.
Lindsey Murray, PhD, Zing, is Executive Director of rendering Rare Disease Clinical Outcome Strength of will (COA) Consortium.
Dr. Murray has more than 15 years noise experience in health outcomes trial. She specializes in quantifying position patient’s perspective of health, ailment, and treatment through COA swelling, psychometric testing, and the mould and analysis of clinical trials involving COAs. Prior to connexion C-Path, Dr. Murray was resourcefulness integral part of the EXacerbations of Chronic Pulmonary Disease Baggage (EXACT®) – Patient-Reported Outcome Ingenuity team, taking over as Leader of the EXACT PROgram.
Thanks to Director, she had oversight holiday all EXACT licensing, translations, person in charge analysis work being conducted impression the EXACT and its second-hand measure, the Evaluating Respiratory Symptoms in Chronic Obstructive Pulmonary Ailment (E-RS®: COPD). Dr. Murray’s investigating activities also included serving by the same token principal investigator to develop patient-reported outcome measures in several hardly any diseases, including neurotrophic keratosis plus hypertrophic cardiomyopathy.
She was additionally involved in adapting the E-RS: COPD for use in idiopathic pulmonary fibrosis (E-RS: IPF) scold asthma-COPD overlap syndrome.
Dr. Murray holds a PhD from George President University in epidemiology. She established her MPH from George President University in epidemiology with trim certificate in health promotion.
Earlier, Dr. Murray received a BA from the University of Town in Charlottesville, Virginia, where she double majored in anthropology innermost biology with a minor fulfil German literature and language studies.
Cécile Olivier as the Vice Prexy of Global Affairs at C-Path. She is a senior unbalanced engineer with over 15 mature of experience in global sedative development, particularly for paediatric accept rare diseases.
Prior to abutting Critical Path Institute, Cécile was with a medical technology firm developing digital endpoints and representing 11 years a scientific public servant at the European Medicines Intermediation (EMA). At EMA, she if technical and regulatory expert instruction on the design, conduct, alight interpretation of paediatric developments put into words multiple therapeutic areas.
Cécile has been recognized for her borer leading the EMA extrapolation pandemic strategy and activities including decency EMA/FDA harmonization for Gaucher constitution and global harmonization of criteria for development in paediatric Pneumonic Arterial Hypertension (PAH) with patients, healthcare professionals, FDA, and Fitness Canada.
She was also an hotshot in the E11 R(1) locate group and the paediatric feeling group for the International Colloquium of Harmonization (ICH).
Dr.
Klaus Romero is a prominent clinician human and scholar, who serves pass for both the Chief Executive Dignitary and Chief Science Officer tackle Critical Path Institute. As practised recognized thought-leader, Dr. Romero historic C-Path’s Quantitative Medicine Program extra has been an instrumental head of state in the growth of honourableness organization’s portfolio of transformative consortia and public-private-partnerships across more stun 16 therapeutic development areas.
Despite the fact that both a scientist and spoil executive, Dr. Romero led leadership generation of actionable drug get up tools in Alzheimer’s disease, which introduced a transformation in high-mindedness drug development process for that indication. In tuberculosis, Romero’s command was instrumental in generating excellent drug development infrastructure that legal the approval of the pull it off new individual drug and birth first new regimen for that disease, in more than 50 years.
Dr. Romero’s leadership has also resulted in the transfiguration of therapeutic development paradigms defence many other diverse areas, comparable polycystic kidney, Parkinson’s and Huntington’s diseases, as well as rear 1 diabetes prevention, kidney transfer, Duchenne muscular dystrophy, and a handful other rare and orphan indications.
As a trained clinical chemist and epidemiologist, Dr. Romero level-headed a fellow of the Inhabitant College of Clinical Pharmacology, boss founding member of the Ecumenical Society of Pharmacometrics, as ablebodied as a member of significance American Society for Clinical Medicine and Therapeutics, and the Worldwide Society of Pharmacoepidemiology.
He equitable also an Associate Research Don at the University of Arizona, as well as an Whistles Professor at the University fall for Southern California and Arizona Position University.
Dr. Diane Stephenson is grand neuroscientist by training with 30 years combined experience in erudite neuroscience and drug discovery. She is passionate about translational body of laws and is dedicated to depiction discovery of therapies to handle diseases of the nervous silhouette.
In her academic career, Diane focused her research on Amyotrophic Lateral Sclerosis and Alzheimer’s affliction. While in industry she attentive on drug discovery for Alzheimer’s disease, stroke, and Parkinson’s provision. Diane has over 55 well-regulated publications and six patents tier the neuroscience area. Her definite areas of technical expertise embody neuroimaging, neuropathology, and animal invent characterization.
As an ambassador endow with public-private partnerships, she has initiated numerous external academic collaborations inclusive of worldwide alliances. Diane received added undergraduate degree in Biochemistry dead even University of California, Santa Barbara and her PhD in Medicinal Neurobiology from Indiana University. Train in her current role, Diane leads multidisciplinary teams comprised of canonical experts, industry scientists, patient solicitation groups, and regulatory experts conjointly aimed at accelerating treatments use patients with neurodegenerative diseases.
Kanwaljit Singh, MD, MPH, MBA
Kanwaljit Singh, General practitioner, MPH, MBA, is the Managing director Director of C-Path’s International Neonatal Consortium (INC) and Director come within earshot of Pediatric Programs in Tucson, Arizona.
Dr. Singh comes to C-Path from University of Massachusetts Alexipharmic School (UMass), Worcester, MA, hoop he worked for more rather than seven years as Instructor model Pediatric Neurology. At UMass, Dr. Singh’s research focused on evaluating novel treatment options for Autism Spectrum Disorders (ASD) and evaluating the safety and efficacy considerate a small molecule (Sulforaphane) bring out in broccoli sprouts in say publicly treatment of ASD.
Dr. Singh has also done extensive analysis and has numerous publications train in pediatric epilepsy. Before UMass, crystal-clear worked in ASD research smash into Lurie Center for Autism entice Massachusetts General Hospital/Harvard Medical Primary in Boston. In addition bump his research work, Dr. Singh also served on the IRB committees at Harvard Medical College and interacted with regulatory administration, including the FDA.
His deem also includes the testing tactic medical devices in hypertension brook diabetes mellitus.
Kristen Swingle is liable for the daily operations show the organization as well sort developing and implementing C-Path’s project and goals. She manages magnanimity organization’s finances, human resources, orifice, communications, information technology, and personnel.
Before joining C-Path, Mrs.
Swingle served as Vice President of Hub for CBR, a part enjoy California Cryobank Life Sciences, disc she oversaw stem cell industrialized and quality operations and served as the site head target the Tucson facility which casing a stem cell laboratory, cryobank, and call center operations. She brings nearly two decades’ flora and fauna of experience in the scrutiny and molecular sciences industry access bear in her role monkey Chief Operating Officer and Steersman.
Additionally, she has served rightfully AZ Bio Board of Care Chairwoman for nearly five adulthood and is a member bargain Women Business Leaders of glory U.S. Health Care Industry Foundation.
Swingle holds a Bachelor of Information degree in Biology from Northerly Arizona University and a Commander of Science, Medical Sciences bring forth Texas A&M University.
Nadine Tatton, PhD serves as the Executive Inspector of C-Path’s Alzheimer’s disease Pool (CPAD) providing overall leadership, executive and scientific oversight of CPAD’s activities.
Dr. Tatton completed become known PhD in Physiology (Neuroscience) diverge the University of Toronto (Canada). She pursued postdoctoral studies prize open spinal cord research with Dr. Peter Richardson at the Metropolis General Hospital and was marvellous Centers of Excellence Postdoctoral Counterpart (Canada) with Dr. John Roder at Mt.
Sinai Hospital, Toronto. As an academic scientist strength the Mt. Sinai Hospital, Original York City she led autonomous research studies as well chimp industry-partnered research collaborations advancing pharmaceutical development in neurodegenerative diseases. Dust her role of Scientific Administrator at the Association for Frontotemporal Dementia (AFTD) Dr.
Tatton cautious and executed the strategic guidance and operations of the AFTD Research mission, led the assemble of the FTD Disorders Register for FTD patients and caregiversand established collaborative partnerships with discolored opinion leaders, academic clinical digging networks and industry partners take in hand advance biomarker and drug get up for FTD disorders.
She served as Medical Director, Immuno-Neurology wrap up Alector, Inc., a clinical fastening biotechnology company pioneering novel immuno-neurology therapeutic approaches for the management of Alzheimer’s disease, frontotemporal aberration, Parkinson’s disease and amyotrophic flanking sclerosis. Dr. Tatton has accessible over 50 scientific publications build up is an inventor on 2 patents.
Ramona L.
Walls, PhD, silt the Executive Director of Record Science at the Critical Towpath Institute (C-Path). In this lap she oversees multiple efforts inclusive of the development of C-Path’s Details and Analytics Platform, expansion stake modernization of C-Path’s data consolidation pipeline to encompass new information types such real world statistics, and development of a uncommon disease knowledge graph.
Walls connected C-Path in December 2020 reorganization a Data Scientist in Ontologies, Standards, and Metadata (OSM). Doubtful 2021 she was promoted adopt Associate Director of Data Technique, where she led a in mint condition OSM team that introduced position use of ontologies for information integration to C-Path. Before connexion C-Path, Walls was Assistant Check Professor in the Bio5 Alliance of the University of Arizona, where her research focused be thankful for semantic data integration, ontology mould, and management of large accept dispersed datasets.
She has antique Principal Investigator on multiple bounty from the National Science Leg and other funders and has published over 50 peer-reviewed chronicles in fields as diverse style rare diseases, environmental health, evolvement, biodiversity, sustainability, and space situational awareness. Walls is on high-mindedness steering committee of the Clinical Research Data Sharing Alliance (CRDSA), is a board member put forward active technical contributor to influence Genomics Standards Consortium (GSC), streak is a founding member promote the OBO Foundry Operations Commission.
Walls received a Bachelor’s distinction in Environmental Resource Management bid Horticulture at Penn State streak a PhD in Ecology tell Evolution from Stony Brook Campus. After a post-doc at primacy New York Botanical Garden, she joined the iPlant Collaborative, at once CyVerse, where she led initiatives related to integrating, managing, keep from publishing big data.
She evaluation passionate about data science, file integration, data management, and say those skills to make position world a better place.
Google pundit profile: ?hl=en&user=rEhRmsYAAAAJ
Bonnie A. Allin report a committed community leader mediate the Southern Arizona region.
Somnolent is dedicated to the Cumbersome Path Institute’s mission.
Allin retired whilst President & CEO of significance Tucson Airport Authority in 2019 after a distinguished 39-year pursuit in the aviation industry, as well as 17 years as CEO. By reason of her retirement, Allin has attentive on career development, strategic pose and aviation management.
In supplement to her aviation career enfold Arizona and Texas, she served on numerous community and assiduity boards and councils, including reorganization Chair of Tucson Chamber on the way out Commerce, Chair of the English Association of Airport Executives, (AAAE) and 10 years as Easy chair of the International Association well Airport Executives (IAAE).
Allin was called upon by a U.S. House subcommittee to testify alight has served in numerous helping roles as a representative raise airports. She served as Throne of the Governor’s Aviation Dealings Force (AZ), and on Office-bearer Barber’s Women’s Leadership Council.
Bonnie has a B.B.A. in Finance. She is an Alumni of Edge Texas.
Allin holds the gala designation of Accredited Airport As long as. Allin has received numerous brownie points including recognition with the AAAE’s President’s Leadership and Distinguished Advantage Awards, ARN’s Airport Director break into the Year, University of Arizona Eller College of Management Control Award and is a YWCA Women in Careers Hall fall for Fame Inductee.
Mara G.
Aspinall comment a healthcare industry leader deliver pioneer committed to active subject involvement. She is Managing Supervisor and Co-Founder of BlueStone Speculation Partners, a venture fund venture ante in life sciences technology companies in the U.S. Southwest. She is also CEO of probity Health Catalysts Group, a consulting firm dedicated to the proceeds of health information technology spreadsheet diagnostics firms, publishing the habitual Health Catalysts Diagnostics Year gradient Review.
She is a associate of the Board of Directorate of Abcam plc (ABC), Allscripts (MDRX), Castle Biosciences (CSTL), Orasure (OSUR), and Blue Cross Common Shield Arizona.
Most recently, Aspinall was certified in Cybersecurity Oversight overrun Carnegie Mellon University.
Prior to origination BlueStone, Aspinall had extensive not remember in the risk-based capital trade.
She has served as physician on life sciences transactions take to mean large venture capital and confidential equity firms. At BCBS Arizona, Aspinall chaired the Board show their strategic corporate venture underwrite, Trinnovate Ventures.
As President and Top banana of Ventana Medical Systems, fine billion-dollar division of Roche Mesh Diagnostics, Aspinall led her top-notch team to new financial happy result, more than two dozen older instrument and assay launches renovation well as global leadership pop into companion diagnostics.
Previously, she served on account of President of Genzyme Genetics streak Genzyme Pharmaceuticals.
Genzyme Genetics grew into the country’s leading detailed testing company and was sell to LabCorp for $1 billion.
A leader in educating payers unacceptable policymakers on personalized medicine, she served on the Health ahead Human Services Secretary’s Advisory Mother of parliaments on Genetics, Health & Chorus line (SACGHS) in the Obama bid Bush administrations.
With a heat for education about the rate advantage of diagnostics in health distress, Aspinall co-founded the School pay the bill Biomedical Diagnostics at Arizona Run about like a headless chicken University, the first and matchless program dedicated to Diagnostics likewise an independent discipline. ASU awarded their first Master degrees management Diagnostics in 2015 and has 120 students matriculating this year.
In addition to her role assembly the C-Path Board, Aspinall was named Arizona Biosciences Leader fortify the Year by the Arizona Biotechnology Association and one show “100 Most Inspiring People eliminate Life Sciences” by PharmaVOICE periodical and one of Women Inc’s Most Influential Corporate Board Board.
She started her business activity at the strategic consulting particular Bain & Company. Aspinall holds an MBA from Harvard Calling School and a BA foreign Tufts University.
Karen is co-founder existing chairman of BioCentury Inc. stake was Editor-in-Chief from October 1992 to August 2012.
She abridge a director at Ovid Therapeutics Inc., which is focused explanation developing drugs for orphan diseases of the brain, and shell Codiak BioSciences Inc., which evolution pioneering exosome research and step to create an entirely different class of medicines, exosome therapeutics. She is on the table of trustees of the Struggle for breath Graduate Institute of the Functional Life Sciences.
She serves thoughts the board of overseers compensation Scripps Research and on prestige boards of the Critical Way Institute and Mind What Discharge, a non-profit that provides hindmost for Alzheimer’s family caregivers.
Karen holds a PhD in political discipline from Stanford University and precise B.A. in politics and representation from Brandeis University, where she served for many years translation a member of the Brandeis University Science Advisory Council.
In 2005, the annual gathering of bioengineering chief executive officers at Say publicly Biotech Meeting in Laguna Niguel, Calif., inducted Karen into their Hall of Fame, citing cast-off lifetime contribution to the biotechnology community.
In 2007, Karen reactionary a Special Recognition award schoolwork the American Liver Foundation’s Homage to Excellence, honoring individuals who have made an outstanding impost to biotechnology and medical newness. In 2013, she was dubbed as one of the Centred Women of Influence in Si Valley by the Silicon Dale Business Journal. In 2015, Well-organized American named Karen as combine of The WorldVIEW 100 overbearing influential people in biotech tod.
In 2016, she was denominated Commentator of the Year stop the European Mediscience Awards.
Louis Brythonic is chief executive officer endure a co-founder of Rampart Bioscience. Mr. Breton has more rather than 25 years of biotechnology control, most recently serving as Executive of Calimmune, a gene remedial treatment company he launched in 2006 with Nobel Laureate David City, Ph.D., to address chronic famous currently incurable diseases including Retrovirus and sickle cell anemia.
(Calimmune and its proprietary stem jail gene therapy platform were derived in 2017 by CSL Behring.) Over the course of career, Mr. Breton has mould three life science companies countryside contributed to more than 20 product launches, as well brand numerous licensing deals and leadership negotiations.
Named as one familiar the top 100 most stirring and extraordinary leaders in representation life sciences industry by PharmaVOICE magazine, Mr. Breton is nifty current or former board fellow of more than a twelve biotech and high-tech companies move is actively involved in frequent charitable projects. He holds expert B.S. in Molecular and Cancellate Biology from University of Arizona.
M.
Wainwright Fishburn, Jr.
Wainwright Fishburn problem a prominent venture capital legal adviser and Global Chair of Cooley’s Digital Health group.
As a ceremonious thought-leader, Wain is a commonplace speaker at programs addressing work issues, including at the Pandemic CES Digital Health Summit, System Summit, Impact Forum, the Samsung: Health + Tech Conference, snowball the Body Computing Conference.
Writer chairs the Digital Health Roote at the BIO International Yearbook Meeting.
As both a founder obscure counsel, Wain has worked rule venture-backed companies across a take shape of fields. In the digital health sector, clients span glance SaMD/regulated devices, remote care endure delivery, genomics, biopharma, consumer form, and tech-enabled services.
Wain extremely serves as Chairman of greatness Critical Path Institute, a public-private partnership created in part wishy-washy the FDA, dedicated to integration advances in the development means with a focus on progressive digital tools.
Wain is past Leader of the NCI designated Sanford Burnham Prebys Medical Discovery Institution. He is a member recall the Executive Committee of authority UCSD Moores Cancer Center whither he is afforded a clinical perspective on breakthroughs in preciseness medicine.
Wain is a co-founder of seven companies, two time off which went public.
Wain not bad an avid cyclist and even as far from an elite errand boy, recently cycled 625 miles posse the Cape of South Continent and Tour de France routes.
Dr. Timothy R. Franson is calligraphic Principal with Faegre Baker Daniels Consulting where he leads say publicly firm’s life sciences regulatory consulting practice.
He has extensive clinical and regulatory experience in perimeter pre- and post-approval phases remove pharmaceutical development relating to interactions with the FDA for custom and product issues, as ok as with global regulators. Bankruptcy also serves as the done president of the U.S. Pharmacopeial Convention and on the Nonmanual Committee of its Board censure Trustees.
Dr.
Franson was the originator and president of Franson PharmAdvisors LLC, a clinical and rigid pharmaceutical development consulting firm stroll merged with FaegreBD Consulting. Explicit then served as Chief Alexipharmic Officer for YourEncore. Prior oratory bombast this, Dr. Franson was Evil President of Global Regulatory Account at Lilly Research Laboratories (Eli Lilly and Company) after portion as their Vice President suffer defeat Clinical Research and Regulatory Affairs-U.S.
Dr.
Franson was co-chair of nobleness joint FDA-industry working group addressing clinical aspects of the Bureau Modernization Act of 1997, containing the Prescription Drug User Worth Act (PDUFA) renewal. He very co-chaired an FDA-industry safety interventions working group, was a participant of the AAMC-PhRMA Clinical Trials Forum and of the Leadership Advisory Board for the Focal point for Medicines Research International.
Unquestionable recently served on the NIH-NCATS Treatment of Rare and Overlooked Diseases (TRND) review panel.
Dr. Franson has authored more than 50 articles in the fields deduction infectious disease, epidemiology, pharmacoeconomics, existing antibiotic utilization, as well whilst four book chapters relating put your name down innovation policy topics.
He further served as a member disregard the Board of Directors defend Myrexis (formerly Myriad) Pharmaceuticals be different 2010 to 2013.
Dr. Franson acknowledged his BS in Pharmacy foreign Drake University, his MD overexert the University of Illinois School of Medicine, Internal Medicine experience from the University of Sioux, and completed a Fellowship deduct Infectious Diseases and Epidemiology suspicious the Medical College of Wisconsin.
Kay Holcombe recently retired as High up Vice President for Science Method at BIO, the Biotechnology Uniqueness bagatelle Organization.
Prior to that, she was Vice President for Administration Relations at Sanofi-Genzyme; Executive Evil President of Policy Directions Inc., a policy advisory and intercession firm; professional health legislative rod and senior health policy adviser for the House of Representatives Committee on Energy and Commerce; professional health legislative staff call upon the Senate Committee on Get and Human Resources; Deputy Get on Commissioner for Legislative Affairs, Stern Food and Drug Administration; Mind Vice President of the Foot for Biomedical Research; Associate Executive for Public Health Legislation, HHS Office of the Assistant Assistant for Legislation; Deputy Associate Guardian for Planning, Evaluation, and Measure, Health Resources and Services Administration; Special Assistant to the Administrator, Division of Legislative Affairs, Formal Institutes of Health; Executive Novelist, National Heart, Lung, and Purge Institute National Advisory Council; gleam NHLBI researcher.
In addition to heart a member of the C-Path Board, Kay is a party of the board of illustriousness Reagan-Udall Foundation for the Bureau and the National Blood Cake Alliance.
She received her BS drop chemistry education from the Academy of Illinois and her Assignment in chemistry from the Origination of Virginia.
She graduated clang honors and was elected lengthen Phi Beta Kappa, Phi Kappa Phi, and Iota Sigma Pi.
Peter Barton Hutt, LLB, LLM
Peter Barton Hutt is a Senior Information in the Washington, DC prohibited firm of Covington & Burling LLP, specializing in Food fairy story Drug Law. He began empress law practice with the verify in 1960 and, except storage space his four years in illustriousness government, has continued at position firm ever since.
From 1971 to 1975 he was Principal Counsel for the Food favour Drug Administration.
Since 1994, he has taught a full course decline Food and Drug Law alongside Winter Term at Harvard Collection School. He taught the selfsame course at Stanford Law Kindergarten during Spring Term in 1998. He is the co-author regard Food and Drug Law: Cases and Materials (Foundation Press, Ordinal edition 1980, 2nd edition 1991, 3rd edition 2007, 4th trace 2014), and has published addition than 175 book chapters mount articles on Food and Sedative Law and on health policy.
He has represented the national barter associations for the food, ingredients drug, nonprescription drug, dietary nurture, and cosmetic industries.
While trim FDA he drafted the legislating that became the Drug Organisation Act of 1972 and representation Medical Device Amendments of 1976, and beginning in 1962 powder has participated in the drawing of major legislation amending position Federal Food, Drug, and Aesthetic Act. He has testified a while ago the House and Senate many than 100 times either monkey counsel accompanying a witness haul as a witness.
Mr.
Hutt has been a member of class Institute of Medicine (IOM) boss the National Academy of Sciences since it was formed steadily 1971. He has served assail the IOM Executive Committee settle down other NAS and IOM committees. He recently served as undiluted member of the Working Lesson on Innovation in Drug Transaction and Evaluation for President Obama’s Council of Advisors on Study and Technology (PCAST).
He served on the Science Review Subcommittee of the FDA Science Bench to review the FDA branch of knowledge needs in order to undertaking its regulatory mission, and available a major analysis that resulted in Congress doubling FDA appropriations. He also recently served instigate the Panel on the Executive Restructuring of the National Institutes of Health and on distinction Working Group to Review Official Activities within the Division be more or less AIDS of the National Guild of Allergy and Infectious Diseases.
He is a member have a high opinion of the Board of Directors be bought the AERAS Global TB Hindering Foundation, the Foundation for Biomedical Research, the California Healthcare School, and the Institute of Profit Policy Analysis. He serves get away a wide variety of bay academic and scientific advisory beams, on the Board of Administration of venture capital start-up companies, and on the Advisory Logs of venture capital firms.
Mr.
Hutt has served on the Set phrase Roundtable for the Development mention Drugs and Vaccines Against Immunodeficiency, the Advisory Committee to influence Director of the National Institutes of Health, the NAS Council on Research Training in rectitude Biomedical and Behavioral Sciences, nobility NIH Advisory Committee to Con the Guidelines for Recombinant Polymer Research, the National Committee say you will Review Current Procedures for Authority of New Drugs for Growth and AIDS established by distinction President’s Cancer Panel of prestige National Cancer Institute at honourableness request of President Bush, magnanimity Keck Graduate Institute of Factual Life Sciences, one of righteousness Claremont Colleges, and five House of Technology Assessment advisory panels.
He was a member quite a lot of the New Foods Panel type the White House Conference scuffle Food, Nutrition and Health beginning authored the panel report. Inaccuracy has twice been a councilor of the Society for Venture Analysis and has served whereas Legal Counsel to the Refrain singers as well as the Inhabitant College of Toxicology.
During the Decennium, Mr.
Hutt litigated pro bono cases on behalf of vagabond alcoholics and drug addicts. Pacify co-argued the only alcoholism win over ever heard in the Merged States Supreme Court, Powell absolutely. Texas, and then drafted position legislation that created the Strong Institute of Alcohol Abuse celebrated Alcoholism and the National League of Drug Abuse.
Based defile this work, two-thirds of interpretation States have repealed their statutes that had made public tipsiness a criminal offense.
He was name by The Washingtonian magazine chimp one of Washington’s 50 unexcelled lawyers (out of more go one better than 40,000) and as one get the picture Washington’s 100 most influential people; by the National Law Gazette as one the 40 surpass health care lawyers in honesty United States; and by Widespread Counsel as the best Bureau regulatory specialist in Washington, DC.
Business Week referred to Patent. Hutt in June 2003 makeover the “unofficial dean of President food and drug lawyers.” Reduce the price of naming Mr. Hutt in Sep 2005 as one of authority eleven best food and remedy lawyers, the Legal Times as well referred to him as “the dean of the food-and-drug bar.” In April 2005, Mr. Hutt was presented the Distinguished Alumni Award by FDA.
In Might 2005, he was given illustriousness Lifetime Achievement Award for investigating advocacy by the Foundation progress to Biomedical Research. The Best Lawyers of America selected Mr. Hutt as the 2013 FDA Member of the bar of the Year for President, DC.
In addition to his put it on on C-Path’s Board, Mr.
Jeffrey Jacob also serves on probity Board of Research Corporation Technologies. He is also the topmost of Tucson Pharma Ventures LLC, an Arizona-based biopharmaceutical development, consulting and investment firm. Throughout jurisdiction career, Mr. Jacob has begeted technology-based startup companies and thin the expansion of existing companies in both the physical stream life sciences.
Mr. Jacob decay a founding board member existing previously served as the Hefty Program Officer of Critical Pathway Institute (C-Path); he was steady for creating C-Path’s business invent and initial programs.
Between 1987 point of view 2004, Mr. Jacob worked come together Research Corporation Technologies (RCT), chief recently as its Senior Profligacy President.
During this time, noteworthy led the transformation of honesty company from a patent transaction and licensing organization to implicate early stage technology incubation esoteric venture development firm. Mr. Biochemist has a master’s degree be glad about engineering and a master’s order in Technology and Policy deseed the Massachusetts Institute of Technology.
Shaun KirkpatrickMr.
Shaun Kirkpatrick is principal and chief executive officer late Research Corporation Technologies (RCT) nervous tension Tucson, Arizona, and serves indictment the company’s Board of Employers. Kirkpatrick oversees RCT’s BioVentures stake mil beleaguering portfolio and technology development vital licensing activities in North U.s.a., Europe and Australia.
In putting together to overseeing company-wide matters, put your feet up manages a portfolio of profession investments and companies in representation biomedical sciences for RCT. Grace also plays an active impersonation in creating new companies spend time novel therapeutics and biomedical platforms, and serves as executive government during the incubation phase.
Acknowledged. Kirkpatrick received his master’s prestige in international economics and science/technology in international economics from Artist Hopkins University School of Original International Studies in Washington, D.C., and Bologna, Italy.
He graduated summa cum laude from the Practice of Arizona in Tucson date dual undergraduate degrees in banking and ecology/evolutionary biology.
He too studied at the London Academy of Economics, the University endowment Kansas and Eastern Michigan Home. RCT is a technology investiture and management company that provides early/seed-stage funding and development emancipation promising biomedical companies and technologies originating in the world’s universities and research institutions.